GlassScriptPhysician profile
Erika Leigh Jacumin
NPI 1548443518
$4,227.52
in general payments reported to CMS, 2019-2025
21 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,514 · 2022: $138 · 2023: $17.06 · 2024: $1,409 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,452 · Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,452.13 |
| Food and Beverage | $1,124.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,099.03 | 2021-2025 | Vercise, General - Dbs |
| Medtronic, INC. | $892.59 | 2025 | Percept PC Brainsense |
| Abbvie INC. | $427.84 | 2021-2025 | |
| Greenwich Biosciences, INC. | $127.65 | 2021 | |
| Csl Behring | $85.31 | 2021 | |
| Genzyme Corporation | $68.92 | 2021 | |
| Acorda Therapeutics, INC | $64.37 | 2021 | |
| Biogen, INC. | $62.56 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $58.73 | 2025 | Crexont |
| Novartis Pharmaceuticals Corporation | $56.97 | 2021 | |
| Ucb, INC. | $55.74 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $43.42 | 2021 | |
| Amgen INC. | $42.98 | 2021 | |
| Sunovion Pharmaceuticals INC. | $24.35 | 2021 | |
| Avanir Pharmaceuticals, INC. | $23.05 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $22.31 | 2021 | |
| Horizon Therapeutics Plc | $15.94 | 2021 | |
| Lilly USA, LLC | $15.45 | 2021 | |
| Tanabe Pharma America, INC. | $15.41 | 2021 | |
| Adamas Pharmaceuticals, INC. | $12.91 | 2021 | |
| Livanova USA, INC. | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Jacumin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.